Rapalogix Health
New York, US · Founded 2023 · Delaware corporation
Biotech
Founders & leadership
JH
Juliette HanExecutive Officer, Director
RM
Rahul MehtaExecutive Officer
BS
Brent SaundersExecutive Officer, Director
JP
James PeyerDirector
DN
David NicholsonDirector
JM
Joan MannickDirector
DD
Doris DayDirector
Reported raises · per SEC filings
Form D private placements▶$19.1MraisedJun 2026 · 28 investors · BiotechnologyRule 506(b)
▶$19.1MraisedJun 2026 · 28 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rahul MehtaExecutive Officer
- Juliette HanDirector
- Neetu DhaliwalDirector
- Brent SaundersDirector
- Doris DayDirector
- James PeyerDirector
- David NicholsonDirector
- Craig GordonDirector
- Offering amount
- $25M
- Amount sold
- $19.1M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$9.1MraisedJun 2025 · 24 investors · BiotechnologyRule 506(b)
▶$9.1MraisedJun 2025 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David NicholsonDirector
- James PeyerDirector
- Juliette HanExecutive Officer, Director
- Rahul MehtaExecutive Officer
- Joan MannickDirector
- Doris DayDirector
- Brent SaundersExecutive Officer, Director
- Offering amount
- $13.5M
- Amount sold
- $9.1M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Rapalogix Secures $20M for Skincare Pipelineallsci.com · 2026
- Rapalogix Health Closes $20 Million Series A Financing to Accelerate Re-Q Health Expansion and Advance Prescription Therapeutics Pipeline - BioSpacebiospace.com · 2026
- Exclusive: Brent Saunders' latest dermatology bet gets $20M for skin longevityendpoints.news · 2026
- Rapalogix Health Raises $20 Million in Series A Financing to Redefine the Future of Longevity-Based Skin Health - BioSpacebiospace.com · 2026

